Drug major Merck Friday reported a loss in its third quarter, compared to last year's profit, hurt by a hefty charge and weak sales. Both adjusted earnings and top line missed market estimates. However, sales of KEYTRUDA and animal health increased from last year. Further, the company lifted its forecast for fiscal 2017 earnings and revenues, above market view.
from RTT - Earnings http://ift.tt/2ySuye7
via IFTTT
No comments:
Post a Comment